|
1
|
Ahmed S, Hasan MM, Heydari M, Rauf A,
Bawazeer S, Abu-Izneid T, Rebezov M, Shariati MA, Daglia M and
Rengasamy KR: Therapeutic potentials of crocin in medication of
neurological disorders. Food Chem Toxicol.
145(111739)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bakac ER, Percin E, Gunes-Bayir A and
Dadak A: A narrative review: The effect and importance of
carotenoids on aging and aging-related diseases. Int J Mol Sci.
24(15199)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ferreira YAM, Jamar G, Estadella D and
Pisani LP: Role of carotenoids in adipose tissue through the
AMPK-mediated pathway. Food Funct. 14:3454–3462. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Melo van Lent D, Leermakers ETM, Darweesh
SKL, Moreira EM, Tielemans MJ, Muka T, Vitezova A, Chowdhury R,
Bramer WM, Brusselle GG, et al: The effects of lutein on
respiratory health across the life course: A systematic review.
Clin Nutr ESPEN. 13:e1–e7. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sani A, Tajik A, Seiiedi SS, Khadem R,
Tootooni H, Taherynejad M, Sabet Eqlidi N, Alavi Dana SMM and
Deravi N: A review of the anti-diabetic potential of saffron. Nutr
Metab Insights. 15(11786388221095223)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sui J, Guo J, Pan D, Wang Y, Xu Y, Sun G
and Xia H: The efficacy of dietary intake, supplementation, and
blood concentrations of carotenoids in cancer prevention: Insights
from an umbrella meta-analysis. Foods. 13(1321)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ferrante M, Fiore M, Conti GO, Fiore V,
Grasso A, Copat C and Signorelli SS: Transition and heavy metals
compared to oxidative parameter balance in patients with deep vein
thrombosis: A case-control study. Mol Med Rep. 15:3438–3444.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fiore M, Cristaldi A, Okatyeva V, Lo
Bianco S, Oliveri Conti G, Zuccarello P, Copat C, Caltabiano R,
Cannizzaro M and Ferrante M: Dietary habits and thyroid cancer
risk: A hospital-based case-control study in Sicily (South Italy).
Food Chem Toxicol. 146(111778)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Fiore M, Barone R, Copat C, Grasso A,
Cristaldi A, Rizzo R and Ferrante M: Metal and essential element
levels in hair and association with autism severity. J Trace Elem
Med Biol. 57(126409)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Phillips CM, Chen LW, Heude B, Bernard JY,
Harvey NC, Duijts L, Mensink-Bout SM, Polanska K, Mancano G,
Suderman M, et al: Dietary inflammatory index and non-communicable
disease risk: A narrative review. Nutrients.
11(1873)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Huang Y, Kypridemos C, Liu J, Lee Y,
Pearson-Stuttard J, Collins B, Bandosz P, Capewell S, Whitsel L,
Wilde P, et al: Cost-effectiveness of the US food and drug
administration added sugar labeling policy for improving diet and
health. Circulation. 139:2613–2624. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Lee Y, Mozaffarian D, Sy S, Huang Y, Liu
J, Wilde PE, Abrahams-Gessel S, Jardim TSV, Gaziano TA and Micha R:
Cost-effectiveness of financial incentives for improving diet and
health through medicare and medicaid: A microsimulation study. PLoS
Med. 16(e1002761)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chekanov K: Diversity and distribution of
carotenogenic Algae in Europe: A review. Mar Drugs.
21(108)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Elbahnaswy S and Elshopakey GE: Recent
progress in practical applications of a potential carotenoid
astaxanthin in aquaculture industry: A review. Fish Physiol
Biochem. 50:97–126. 2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Azam MS, Choi J, Lee MS and Kim HR:
Hypopigmenting effects of brown algae-derived phytochemicals: A
review on molecular mechanisms. Mar Drugs. 15(297)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hentati F, Tounsi L, Djomdi D, Pierre G,
Delattre C, Ursu AV, Fendri I, Abdelkafi S and Michaud P: Bioactive
polysaccharides from seaweeds. Molecules. 25(3152)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kiran BR and Venkata Mohan S: Microalgal
cell biofactory-therapeutic, nutraceutical and functional food
applications. Plants (Basel). 10(836)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ren Y, Deng J, Huang J, Wu Z, Yi L, Bi Y
and Chen F: Using green alga Haematococcus pluvialis for
astaxanthin and lipid co-production: Advances and outlook.
Bioresour Technol. 340(125736)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Mularczyk M, Michalak I and Marycz K:
Astaxanthin and other nutrients from Haematococcus
pluvialis-multifunctional applications. Mar Drugs.
18(459)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Davinelli S, Nielsen ME and Scapagnini G:
Astaxanthin in skin health, repair, and disease: A comprehensive
review. Nutrients. 10(522)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Basiony M, Ouyang L, Wang D, Yu J, Zhou L,
Zhu M, Wang X, Feng J, Dai J, Shen Y, et al: Optimization of
microbial cell factories for astaxanthin production: Biosynthesis
and regulations, engineering strategies and fermentation
optimization strategies. Synth Syst Biotechnol. 7:689–704.
2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wu Y, Shamoto-Nagai M, Maruyama W, Osawa T
and Naoi M: Phytochemicals prevent mitochondrial membrane
permeabilization and protect SH-SY5Y cells against apoptosis
induced by PK11195, a ligand for outer membrane translocator
protein. J Neural Transm (Vienna). 124:89–98. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ostrom QT, Patil N, Cioffi G, Waite K,
Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report:
Primary brain and other central nervous system tumors diagnosed in
the United States in 2013-2017. Neuro Oncol. 22 (Suppl 2):iv1–iv96.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tan AC, Ashley DM, López GY, Malinzak M,
Friedman HS and Khasraw M: Management of glioblastoma: State of the
art and future directions. CA Cancer J Clin. 70:299–312.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shin J, Nile A, Saini RK and Oh JW:
Astaxanthin sensitizes low SOD2-expressing GBM cell lines to TRAIL
treatment via pathway involving mitochondrial membrane
depolarization. Antioxidants (Basel). 11(375)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shin J, Saini RK and Oh JW: Low dose
astaxanthin treatments trigger the hormesis of human astroglioma
cells by up-regulating the cyclin-dependent kinase and
down-regulated the tumor suppressor protein P53. Biomedicines.
8(434)2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Patel M, Singh P, Gandupalli L and Gupta
R: Identification and evaluation of survival-associated common
chemoresistant genes in cancer. Biomed Biotechnol Res J. 8:320–327.
2024.
|
|
28
|
Tsuji S, Nakamura S, Maoka T, Yamada T,
Imai T, Ohba T, Yako T, Hayashi M, Endo K, Saio M, et al:
Antitumour effects of astaxanthin and adonixanthin on glioblastoma.
Mar Drugs. 18(474)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zheng M, Kumar A, Sharma V, Behl T, Sehgal
A, Wal P, Shinde NV, Kawaduji BS, Kapoor A, Anwer MK, et al:
Revolutionizing pediatric neuroblastoma treatment: Unraveling new
molecular targets for precision interventions. Front Cell Dev Biol.
12(1353860)2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sun SQ, Du FX, Zhang LH, Hao-Shi Gu FY,
Deng YL and Ji YZ: Prevention of STAT3-related pathway in SK-N-SH
cells by natural product astaxanthin. BMC Complement Med Ther.
23(430)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wu H, Niu H, Shao A, Wu C, Dixon BJ, Zhang
J, Yang S and Wang Y: Astaxanthin as a potential neuroprotective
agent for neurological diseases. Mar Drugs. 13:5750–5766.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
García F, Lobos P, Ponce A, Cataldo K,
Meza D, Farías P, Estay C, Oyarzun-Ampuero F, Herrera-Molina R,
Paula-Lima A, et al: Astaxanthin counteracts excitotoxicity and
reduces the ensuing increases in calcium levels and mitochondrial
reactive oxygen species generation. Mar Drugs.
18(335)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang J, Ding C, Zhang S and Xu Y:
Neuroprotective effects of astaxanthin against oxygen and glucose
deprivation damage via the PI3K/Akt/GSK3β/Nrf2 signalling pathway
in vitro. J Cell Mol Med. 24:8977–8985. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Yan T, Ding F, Zhang Y, Wang Y, Wang Y,
Zhang Y, Zhu F, Zhang G, Zheng X, Jia G, et al: Astaxanthin
inhibits H2O2-induced excessive mitophagy and
apoptosis in SH-SY5Y cells by regulation of Akt/mTOR activation.
Mar Drugs. 22(57)2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Korczowska-Łącka I, Słowikowski B, Piekut
T, Hurła M, Banaszek N, Szymanowicz O, Jagodziński PP, Kozubski W,
Permoda-Pachuta A and Dorszewska J: Disorders of endogenous and
exogenous antioxidants in neurological diseases. Antioxidants
(Basel). 12(1811)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Łukasiewicz S, Czeczelewski M, Forma A,
Baj J, Sitarz R and Stanisławek A: Breast cancer-epidemiology, risk
factors, classification, prognostic markers, and current treatment
strategies-an updated review. Cancers (Basel).
13(4287)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ahn YT, Kim MS, Kim YS and An WG:
Astaxanthin reduces stemness markers in BT20 and T47D breast cancer
stem cells by inhibiting expression of pontin and mutant p53. Mar
Drugs. 18(577)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Badak B, Aykanat NEB, Kacar S, Sahinturk
V, Arik D and Canaz F: Effects of astaxanthin on metastasis
suppressors in ductal carcinoma. A preliminary study. Ann Ital
Chir. 92:565–574. 2021.PubMed/NCBI
|
|
39
|
Karimian A, Mir Mohammadrezaei F,
Hajizadeh Moghadam A, Bahadori MH, Ghorbani-Anarkooli M, Asadi A
and Abdolmaleki A: Effect of astaxanthin and melatonin on cell
viability and DNA damage in human breast cancer cell lines. Acta
Histochem. 124(151832)2022.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim MS, Ahn YT, Lee CW, Kim H and An WG:
Astaxanthin modulates apoptotic molecules to induce death of SKBR3
breast cancer cells. Mar Drugs. 18(266)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Lu Z, Long Y, Li J, Li J, Ren K, Zhao W,
Wang X, Xia C, Wang Y, Li M, et al: Simultaneous inhibition of
breast cancer and its liver and lung metastasis by blocking
inflammatory feed-forward loops. J Control Release. 338:662–679.
2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
McCall B, McPartland CK, Moore R,
Frank-Kamenetskii A and Booth BW: Effects of astaxanthin on the
proliferation and migration of breast cancer cells in vitro.
Antioxidants (Basel). 7(135)2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Shokrian Zeini M, Pakravesh SM, Jalili
Kolour SM, Soghala S, Dabbagh Ohadi MA, Ghanbar Ali Akhavan H,
Sayyahi Z, Mahya L, Jahani S, Shojaei Baghini S, et al: Astaxanthin
as an anticancer agent against breast cancer: An in vivo and in
vitro investigation. Curr Med Chem: Apr 17, 2024 (Epub ahead of
print).
|
|
44
|
Vijay K, Sowmya PRR, Arathi BP, Shilpa S,
Shwetha HJ, Raju M, Baskaran V and Lakshminarayana R: Low-dose
doxorubicin with carotenoids selectively alters redox status and
upregulates oxidative stress-mediated apoptosis in breast cancer
cells. Food Chem Toxicol. 118:675–690. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Malhão F, Ramos AA, Macedo AC and Rocha E:
Cytotoxicity of seaweed compounds, alone or combined to reference
drugs, against breast cell lines cultured in 2D and 3D. Toxics.
9(24)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Sowmya PRR, Arathi BP, Vijay K, Baskaran V
and Lakshminarayana R: Astaxanthin from shrimp efficiently
modulates oxidative stress and allied cell death progression in
MCF-7 cells treated synergistically with β-carotene and lutein from
greens. Food Chem Toxicol. 106:58–69. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Yuri T, Yoshizawa K, Emoto Y, Kinoshita Y,
Yuki M and Tsubura A: Effects of dietary xanthophylls,
canthaxanthin and astaxanthin on N-Methyl-N-nitrosourea-induced rat
mammary carcinogenesis. In Vivo. 30:795–800. 2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Fouad MA, Sayed-Ahmed MM, Huwait EA, Hafez
HF and Osman AMM: Epigenetic immunomodulatory effect of eugenol and
astaxanthin on doxorubicin cytotoxicity in hormonal positive breast
Cancer cells. BMC Pharmacol Toxicol. 22(8)2021.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Atalay PB, Kuku G and Tuna BG: Effects of
carbendazim and astaxanthin co-treatment on the proliferation of
MCF-7 breast cancer cells. In Vitro Cell Dev Biol Anim. 55:113–119.
2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Bharathiraja S, Manivasagan P, Quang Bui
N, Oh YO, Lim IG, Park S and Oh J: Cytotoxic induction and
photoacoustic imaging of breast cancer cells using
astaxanthin-reduced gold nanoparticles. Nanomaterials (Basel).
6(78)2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Kulpreechanan N and Sorasitthiyanukarn FN:
Astaxanthin-loaded chitosan oligosaccharide/alginate nanoparticles:
Exploring the anti-inflammatory and anticancer potential as a
therapeutic nutraceutical: An in vitro study. Res J Pharm Technol.
16:5378–5383. 2023.
|
|
52
|
Burz C, Pop V, Silaghi C, Lupan I and
Samasca G: Prognosis and treatment of gastric cancer: A 2024
update. Cancers (Basel). 16(1708)2024.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Li H, Shen M and Wang S: Current therapies
and progress in the treatment of advanced gastric cancer. Front
Oncol. 14(1327055)2024.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Global Burden of Disease Liver Cancer
Collaboration. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu
MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, et al: The
burden of primary liver cancer and underlying etiologies from 1990
to 2015 at the global, regional, and national level: Results from
the global burden of disease study 2015. JAMA Oncol. 3:1683–1691.
2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Mazzaferro V, Citterio D, Bhoori S,
Bongini M, Miceli R, De Carlis L, Colledan M, Salizzoni M,
Romagnoli R, Antonelli B, et al: Liver transplantation in
hepatocellular carcinoma after tumour downstaging (XXL): A
randomised, controlled, phase 2b/3 trial. Lancet Oncol. 21:947–956.
2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Shao Y, Ni Y, Yang J, Lin X, Li J and
Zhang L: Astaxanthin inhibits proliferation and induces apoptosis
and cell cycle arrest of mice H22 hepatoma cells. Med Sci Monit.
22:2152–2160. 2016.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zhang X, Li W, Dou X, Nan D and He G:
Astaxanthin encapsulated in biodegradable calcium alginate
microspheres for the treatment of hepatocellular carcinoma in
vitro. Appl Biochem Biotechnol. 191:511–527. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Messina CM, Manuguerra S, Renda G and
Santulli A: Biotechnological applications for the sustainable use
of marine by-products: In vitro antioxidant and pro-apoptotic
effects of astaxanthin extracted with supercritical CO2
from parapeneus longirostris. Mar Biotechnol (NY). 21:565–576.
2019.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Li J, Dai W, Xia Y, Chen K, Li S, Liu T,
Zhang R, Wang J, Lu W, Zhou Y, et al: Astaxanthin inhibits
proliferation and induces apoptosis of human hepatocellular
carcinoma cells via inhibition of Nf-Κb P65 and Wnt/Β-catenin in
vitro. Mar Drugs. 13:6064–6081. 2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Yadav K, Saxena A, Gupta M, Saha B, Sarwat
M and Rai MP: Comparing pharmacological potential of freshwater
microalgae carotenoids towards antioxidant and anti-proliferative
activity on liver cancer (HUH7) cell line. Appl Biochem Biotechnol.
196:2053–2066. 2024.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ren P, Yu X, Yue H, Tang Q, Wang Y and Xue
C: Dietary supplementation with astaxanthin enhances anti-tumor
immune response and aids the enhancement of molecularly targeted
therapy for hepatocellular carcinoma. Food Funct. 14:8309–8320.
2023.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ren P, Tang Q, He X, Xu J, Wang Y and Xue
C: Astaxanthin augmented the anti-hepatocellular carcinoma efficacy
of sorafenib through the inhibition of the JAK2/STAT3 signaling
pathway and mitigation of hypoxia within the tumor
microenvironment. Mol Nutr Food Res. 68(e2300569)2024.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Hooi JKY, Lai WY, Ng WK, Suen MMY,
Underwood FE, Tanyingoh D, Malfertheiner P, Graham DY, Wong VWS, Wu
JCY, et al: Global prevalence of Helicobacter pylori
infection: Systematic review and meta-analysis. Gastroenterology.
153:420–429. 2017.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Kim SH and Kim H: Transcriptome analysis
of the inhibitory effect of astaxanthin on Helicobacter
pylori-induced gastric carcinoma cell motility. Mar Drugs.
18(365)2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Lee H, Lim JW and Kim H: Effect of
astaxanthin on activation of autophagy and inhibition of apoptosis
in Helicobacter pylori-infected gastric epithelial cell line
AGS. Nutrients. 12(1750)2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Kim SH and Kim H: Inhibitory effect of
astaxanthin on gene expression changes in Helicobacter
pylori-infected human gastric epithelial cells. Nutrients.
13(4281)2021.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Lee J, Lim JW and Kim H: Astaxanthin
inhibits matrix metalloproteinase expression by suppressing
PI3K/AKT/mTOR activation in Helicobacter pylori-infected
gastric epithelial cells. Nutrients. 14(3427)2022.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Woo J, Lim JW and Kim H: Astaxanthin
inhibits integrin α5 expression by suppressing activation of
JAK1/STAT3 in Helicobacter pylori-stimulated gastric
epithelial cells. Mol Med Rep. 27(127)2023.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Kim JH, Park JJ, Lee BJ, Joo MK, Chun HJ,
Lee SW and Bak YT: Astaxanthin inhibits proliferation of human
gastric cancer cell lines by interrupting cell cycle progression.
Gut Liver. 10:369–374. 2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Kim S, Lee H, Lim JW and Kim H:
Astaxanthin induces NADPH oxidase activation and
receptor-interacting protein kinase 1-mediated necroptosis in
gastric cancer AGS cells. Mol Med Rep. 24(837)2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Han H, Lim JW and Kim H: Astaxanthin
inhibits Helicobacter pylori-induced inflammatory and
oncogenic responses in gastric mucosal tissues of mice. J Cancer
Prev. 25:244–251. 2020.PubMed/NCBI View Article : Google Scholar
|
